Want to join the conversation?
Foster City, California-based biotechnology company $GILD reported 4Q15 net income of $4.7Bil or $3.18 per diluted share versus $3.5Bil or $2.18 per diluted share in 4Q14. Revenue in 4Q15 was $8.5Bil, up from $7.3Bil a year ago. Excluding amounts related to acquisition, stock-based compensation and other, net income was $4.9Bil or $3.32 per share.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)